Advertisements


Medtronic initiates clinical study to assess safety of drug-eluting stents

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 16th, 2018

Clinical study shows safety, efficacy outcomes for Medtronic Resolute Onyx DES

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 23rd, 2018

Emergent BioSolutions initiates Phase 1 clinical study of anti-Zika drug

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 31st, 2018

Pulse Biosciences initiates clinical feasibility study using NPS platform

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 11th, 2018

Achieve Life Sciences" stock rockets on positive study results for smoking cessation drug

Shares of Achieve Life Sciences Inc. shot up 31% to pace all premarket gainers Thursday, after the clinical-stage pharmaceutical company announced positive results from a study of its smoking cessation drug. Volume .....»»

Category: topSource: marketwatchSep 27th, 2018

Medtronic (MDT) Initiates ONYX ONE- Clear Study on DAPT

Medtronic plc MDT continues .....»»

Category: futuresSource: nasdaqSep 12th, 2018

Medtronic initiates Onyx ONE Clear Study in U.S. and Japan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 10th, 2018

Inovio Initiates Dosing in Phase I/IIa Study on MERS Vaccine

Inovio Pharmaceuticals (INO) administers dosage in the first patient under a phase I/IIa trial to assess its MERS vaccine INO-4700. .....»»

Category: smallbizSource: nytSep 7th, 2018

Inovio (INO) Initiates Phase I Study on Hepatitis C Vaccine

Inovio Pharmaceuticals (INO) and Korean partner GeneOne Life Science dose the first patient in a phase I study, which will assess its hepatitis C vaccine GLS-6150. Inovio Pharmaceuticals, Inc. IN.....»»

Category: dealsSource: nytSep 4th, 2018

Weight-loss drug Belviq seems safe for heart, study finds

For the first time, a drug has been shown to help people lose weight and keep it off for several years without raising their risk for heart problems — a safety milestone that may encourage wider use to help curb the obesity epidemic......»»

Category: topSource: washpostAug 26th, 2018

Weight-loss drug Belviq seems safe for heart, study finds

For the first time, a drug has been shown to help people lose weight and keep it off for several years without raising their risk for heart problems — a safety milestone that may encourage wider use to help curb the obesity epidemic......»»

Category: topSource: foxnewsAug 26th, 2018

BioLineRx initiates Phase 1/2a clinical study for AGI-134

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallAug 1st, 2018

J&J"s (JNJ) Phase III Study for Invokana Halted Earlier

Johnson & Johnson's (JNJ) phase III CREDENCE study evaluating the efficacy and safety of its diabetes drug Invokana is being stopped early based on positive pre-specified efficacy data. Johnson & Johnson JNJ .....»»

Category: personnelSource: nytJul 17th, 2018

Advaxis shares rise 68% after FDA lifts clinical hold on its drug trial

Shares of the biotech company Advaxis Inc. surged 68% in premarket trade on Friday after the Food and Drug Administration lifted a clinical hold on the company's phase 1/2 study for a cancer drug combination. The clinical hol.....»»

Category: topSource: marketwatchJul 13th, 2018

CohBar initiates clinical study with first-in-human dosing of CB4211

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 12th, 2018

Advaxis initiates IND with FDA to study first ADXS-HOT drug candidate for NSCLC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 10th, 2018

Biotech ETFs Surge on Biogen"s Positive Drug Trial Result

Biotech ETFs surge on Biogen's encouraging Phase 2 clinical study data for Alzheimer???s treatment. Biogen Inc. BIIB was a star performer in Friday’s trading session, as the stock rallied as much as 23.1% but closed a l.....»»

Category: worldSource: nytJul 9th, 2018

Viveve submits VIVEVE II clinical study patient safety data to FDA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 3rd, 2018

Agios (AGIO) Initiates Phase III Study on PK Deficiency Drug

Zacks.....»»

Category: topSource: redinewsJun 20th, 2018

Agios (AGIO) Initiates Phase III Study on PK Deficiency Drug

Agios Pharmaceuticals, Inc. (AGIO), initiates a phase III ACTIVATE study which will evaluateits lead rare genetic diseases candidate, AG-348 in patients with PK deficiency w.....»»

Category: dealsSource: nytJun 20th, 2018

Inovio Initiates Phase II Study on Pipeline Drug VGX-3100

Inovio (INO) begins a phase II study to evaluate the efficacy of its pipeline candidate VGX-3100 on adult men and women with human papilloma virus (HPV)-related anal dysplasia. Inovio Pharmaceuticals, INO has initiated a .....»»

Category: dealsSource: nytMay 22nd, 2018